Decreased mRNA expression for the two subunits of system xc−, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia
Authors:
- 1 January 2016
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 72, 58-63
Abstract
No abstract availableKeywords
Funding Information
- China Medical University Hospital (DMR-103-085)
- Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002)
This publication has 36 references indexed in Scilit:
- The DAO Gene Is Associated with Schizophrenia and Interacts with Other Genes in the Taiwan Han Chinese PopulationPLOS ONE, 2013
- Translating Glutamate: From Pathophysiology to TreatmentScience Translational Medicine, 2011
- Increased expression of cystine/glutamate antiporter in multiple sclerosisJournal of Neuroinflammation, 2011
- System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNSBritish Journal of Pharmacology, 2011
- Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humansNutrition, 2011
- Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and HumansBiological Psychiatry, 2009
- The role of glutamate transporters in neurodegenerative diseases and potential opportunities for interventionNeurochemistry International, 2007
- Glutathione Pathways in the BrainBiological Chemistry, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001